Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
49.19
+1.55 (+3.26%)
Streaming Delayed Price
Updated: 12:30 PM EST, Feb 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
20,758,439
Open
50.13
Bid (Size)
49.19 (400)
Ask (Size)
49.21 (400)
Prev. Close
47.64
Today's Range
49.01 - 51.09
52wk Range
43.08 - 93.80
Shares Outstanding
N/A
Dividend Yield
2.37%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Hims & Hers Stock Just Got Destroyed
↗
Today 12:02 EST
Everyone's ganging up on Hims & Hers stock this week.
Via
The Motley Fool
Topics
Lawsuit
The GLP-1 Gold Rush Hits a Wall: Novo Nordisk Sues Hims & Hers as FDA Crackdown Triggers 20% Stock Crash
Today 11:35 EST
The multi-billion dollar weight-loss drug market experienced a seismic shift this morning as the era of easy-access compounded alternatives faced its most significant legal and regulatory challenge to...
Via
MarketMinute
Topics
Intellectual Property
Lawsuit
Performance
YTD
-6.1%
-6.1%
1 Month
-16.4%
-16.4%
3 Month
+7.1%
+7.1%
6 Month
-1.4%
-1.4%
1 Year
-41.4%
-41.4%
More News
Read More
FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains
↗
Today 11:21 EST
Via
Stocktwits
Topics
Lawsuit
HIMS Stock Plunges 10% After Hours: FDA Chief Warns Of ‘Swift Action’ On Copycat Drugs After Novo Semaglutide Knockoff Launch
↗
February 05, 2026
Via
Stocktwits
Why Eli Lilly Stock Just Popped
↗
Today 11:05 EST
Via
The Motley Fool
Topics
Lawsuit
The GLP-1 Gold Rush Hits a Wall: Hims & Hers Shares Crater After Abrupt Oral Wegovy U-Turn
Today 10:19 EST
Via
MarketMinute
Topics
Earnings
Intellectual Property
Novo Nordisk Sues Hims & Hers Over Compounded Wegovy, Calls For Permanent Sales Ban: HIMS Stock Tanks
↗
Today 7:36 EST
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
HIMS Stock In Turmoil: Retail Bulls Bet On Rebound, Skeptics See Bloodbath After Compounded Weight-Loss Pill Halt
↗
February 08, 2026
Via
Stocktwits
Topics
Intellectual Property
Law Enforcement
Novo Nordisk Plunges Nearly 15% After Earnings. Here's What Investors Need to Know.
↗
February 08, 2026
Via
The Motley Fool
Medicare Changes in 2026 Every Retiree Needs to Know: The Good, the Bad, and the Ugly
↗
February 08, 2026
Via
The Motley Fool
Topics
Economy
Government
Retirement
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
↗
February 07, 2026
Via
The Motley Fool
Eli Lilly Booms, Then Busts: Stellar Guidance vs Hims Undercut
↗
February 06, 2026
Via
MarketBeat
HIMS Stock Slumps After-Hours On Regulatory Scrutiny On Heels Of Compounded Wegovy Pill Launch
↗
February 06, 2026
Via
Stocktwits
Eli Lilly Projects Record $80B-$83B Revenue for 2026 as Metabolic Franchise Decouples from Competition
February 06, 2026
Via
MarketMinute
Topics
Earnings
Economy
Eli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore
↗
February 06, 2026
Via
The Motley Fool
The $49 Disruptor: Hims & Hers Ignites a Brutal Price War in the Weight-Loss Drug Market
February 06, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Law Enforcement
Why Shares of Novo Nordisk Stock Collapsed This Week
↗
February 06, 2026
Via
The Motley Fool
The Trillion-Dollar Divergence: Eli Lilly Hits Milestone While Novo Nordisk Faces 'Supply Chain Reset'
February 06, 2026
Via
MarketMinute
Topics
Economy
Why Did AMD, Uber, and Novo Nordisk Stock Crash This Week?
↗
February 06, 2026
Via
The Motley Fool
The Phoenix of Big Pharma: A 2026 Deep-Dive into AstraZeneca’s Global Dominance
February 06, 2026
Via
Finterra
Topics
Economy
Government
Intellectual Property
Eli Lilly Stock Has Over 20% Upside, Analysts Say: Retail Seeks Pharma 'Safe Haven' As FDA Targets GLP-1 Copycats
↗
February 05, 2026
Via
Stocktwits
Topics
Fraud
Law Enforcement
Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.
↗
February 05, 2026
Via
The Motley Fool
Trade War 2.0: 25% Tariffs on Chips, Cars, and Medicine Reshape the Global Supply Chain
February 05, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
The Great GLP-1 Divergence: Eli Lilly Surges Toward Trillion-Dollar Dominance as Novo Nordisk Falters on U.S. Price Cuts
February 05, 2026
Via
MarketMinute
Topics
Earnings
Economy
Hims & Hers Takes On Novo Nordisk: What We Know Right Now
↗
February 05, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 49.19
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 02/09/26 12:30 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.